SCHEMBL13611867

SCHEMBL13611867

CCC[C@H]1C[C@@H](CC=O)C[C@H](C2C=CC(C(F)(F)F)=CC2)N1Cc1cc(C(F)(F)F)ccc1C(F)(F)F

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13611866 1.00 — —
SCHEMBL8269240 0.90 FFAR4 (0.35) —
SCHEMBL8269244 0.90 FFAR4 (0.35) —
SCHEMBL13611630 0.90 FFAR4 (0.35) —
SCHEMBL8269012 0.87 FFAR1 (0.31) —
SCHEMBL8269013 0.87 FFAR1 (0.31) —
SCHEMBL8268251 0.87 — —
SCHEMBL13513844 0.82 FFAR4 (0.37) —
SCHEMBL13611611 0.72 FFAR4 (0.42) —
SCHEMBL13611438 0.72 FFAR1 (0.39) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7638629-B2 Piperidines and related compounds for treatment of alzheimer's disease Merck Sharp & Dohme Ltd, (GB) 2009-12-29 — — US disclosed
US-20080021043-A1 Piperidines and Related Compounds for Treatment of Alzheimer's Disease MERCK SHARP & DOHME LTD. (GB) 2008-01-24 — — US disclosed
Send feedback